SCDM Updated CCDM Exam Questions and Answers by selena

Thekey deliverables for User Acceptance Testing (UAT)are theTest Plan, Test Scripts, and Test Results.

According to theGCDMP (Chapter: Database Design and Validation), UAT is the final validation step before a clinical database is released for production. It confirms that the system performs according to user requirements and protocol specifications.

The deliverables include:

UAT Test Plan:Defines testing objectives, scope, acceptance criteria, and responsibilities.

UAT Test Scripts:Provide step-by-step instructions for testing database functionality, edit checks, and workflows.

UAT Test Results:Document actual test outcomes versus expected outcomes, including any deviations and their resolutions.

These deliverables form part of the system validation documentation required underFDA 21 CFR Part 11andICH E6 (R2)to demonstrate that the database has been properly validated.

Project Plans (option A) and Training (option B) occur in earlier phases, while eCRF Completion Guidelines (option D) support site data entry, not system validation.

Reference (CCDM-Verified Sources):

SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Database Design and Validation, Section 5.3 – User Acceptance Testing Deliverables

FDA 21 CFR Part 11 – Validation Documentation Requirements

ICH E6 (R2) Good Clinical Practice, Section 5.5.3 – System Validation Records

TheStudy Schedule of Events(SoE) section in the protocol is the most concise and comprehensive representation of thetiming of data collectionthroughout a study.

According to theGood Clinical Data Management Practices (GCDMP, Chapter: Data Management Planning and Study Start-up)andICH E6 (R2) GCP, the SoE outlines what assessments, procedures, and data collections occur at each study visit (e.g., screening, baseline, treatment visits, follow-up). This table is a foundational tool forCRF design,database structure, andedit-check development, ensuring alignment between the protocol and data management systems.

While thestudy endpoints section (A)defineswhatis measured, and theprotocol synopsis (C)summarizes the design, only theschedule of events (B)specifieswhendata collection occurs for each parameter. TheICH essential documents (D)pertain to regulatory documentation, not study visit timing.

Reference (CCDM-Verified Sources):

SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Data Management Planning and Study Start-up, Section 4.1 – Using the Schedule of Events for Database Design

ICH E6 (R2) GCP, Section 6.3 – Trial Design and Schedule of Assessments

FDA Guidance for Industry: Protocol Design and Data Collection Standards

Inpaper-based trials, site staff (e.g., study coordinators) record data manually on paper Case Report Forms (CRFs), which are later transcribed by data entry personnel into an electronic database.

However, inEDC-based studies, thesite coordinatoris directly responsible forentering data into the EDC system. This eliminates the need for centralized double data entry and shortens data cleaning timelines.

TheGCDMP (Chapter: Electronic Data Capture Systems)states that EDC systems shift certain tasks, includingdata entry, initial query response, and source verification preparation, to the site level. Yet,data entryremains the most significant additional responsibility compared to paper-based studies.

Option A (Query resolution)is performed in both EDC and paper-based systems.

Option C (Data curation)is typically a Data Management function.

Option D (Medical record abstraction)is part of source documentation, not specific to EDC.

Thus,option B (Data entry)is correct — it is the additional site coordinator duty unique to EDC environments.

Reference (CCDM-Verified Sources):

SCDM GCDMP, Chapter: Electronic Data Capture (EDC) Systems, Section 5.3 – Site Responsibilities and Workflow Changes

ICH E6(R2) GCP, Section 5.5.3 – Data Entry and Role Delegation in Computerized Systems

FDA Guidance for Industry: Computerized Systems Used in Clinical Investigations, Section 6.2 – Site-Level Data Entry Controls

Adding multiple new sites late in the enrollment period creates aconcentrated influx of new datanear the end of the study. These sites typically start enrolling patients later, resulting in a“bolus” of Case Report Forms (CRFs)that must be entered, validated, and cleaned within a shorter timeframe to meet database lock deadlines.

According to theGood Clinical Data Management Practices (GCDMP, Chapter: Project Management and Data Flow), late site activation compresses the timeline for data management tasks, necessitating increased resources fordata entry, query management, and cleaning. Data management teams must anticipate this surge and plan accordingly—either by increasing staffing or revising timelines to prevent bottlenecks and maintain quality.

Whileoption D(increased query rates) can occur, it is a secondary effect. Themost direct and consistent impactis the surge in data volume requiring expedited processing near study end.

Reference (CCDM-Verified Sources):

SCDM GCDMP, Chapter: Project Management, Section 5.3 – Managing Changes in Site Activation and Data Flow

ICH E6(R2) GCP, Section 5.1 – Quality Management and Oversight